BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Narkar A, Willard JM, Blinova K. Chronic Cardiotoxicity Assays Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs). Int J Mol Sci 2022;23:3199. [PMID: 35328619 DOI: 10.3390/ijms23063199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Feaster TK, Feric N, Pallotta I, Narkar A, Casciola M, Graziano MP, Aschar-sobbi R, Blinova K. Acute effects of cardiac contractility modulation stimulation in conventional 2D and 3D human induced pluripotent stem cell-derived cardiomyocyte models. Front Physiol 2022;13. [DOI: 10.3389/fphys.2022.1023563] [Reference Citation Analysis]
2 Narkar A, Feaster TK, Casciola M, Blinova K. Human in vitro neurocardiac coculture ( iv NCC ) assay development for evaluating cardiac contractility modulation. Physiological Reports 2022;10. [DOI: 10.14814/phy2.15498] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Maria Cherian R, Prajapati C, Penttinen K, Häkli M, Koivisto JT, Pekkanen-mattila M, Aalto-setälä K. Fluorescent hiPSC-derived MYH6-mScarlet cardiomyocytes for real-time tracking, imaging, and cardiotoxicity assays. Cell Biol Toxicol. [DOI: 10.1007/s10565-022-09742-0] [Reference Citation Analysis]
4 Iachetta G, Melle G, Colistra N, Tantussi F, De Angelis F, Dipalo M. Chronic cardiotoxicity assessment by cell optoporation on microelectrode arrays.. [DOI: 10.1101/2022.06.20.496820] [Reference Citation Analysis]